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Polymorphisms in the Promoter of the Interleukin-4 Receptor a
Chain Gene Are Associated with Atopic Dermatitis in Japan
To the Editor:
The trait of enhanced IgE responsiveness has been linked to
chromosome segment 16p12, where the interleukin-4
receptor a chain (IL4R) gene is located (Deichmann et al,
1998). Recently, Ober et al (2000) suggested that variations
outside the coding region of the IL4R gene might influence
susceptibility to atopy and asthma. We sought to find
promoter polymorphisms of the IL4R gene that might
influence the transcription level of the gene. We found
six polymorphisms: 3112C4T, 1803 T4C, 327C4A,
326A4C, 186G4A, and 184A4G, numbered from the
transcriptional initiation site. A case–control association
study demonstrated significant association at 3112C4T
(p¼0.0075),1803T4C (p¼0.0034),327C4A (p¼0.00033),
326A4C (p¼0.0031), and 186G4A (p¼0.0031) be-
tween patients with atopic dermatitis and normal control
subjects. Nevertheless, none of these IL4R promoter
variants had any effect on transcriptional activity when
tested fused to a luciferase reporter gene. Thus, although
we observed strong association between IL4R promoter
polymorphisms and atopic dermatitis, the biological me-
chanism of action of these variants is not yet clear.
To explore the cis-acting element(s) affecting the
expression of the gene, we analyzed the promoter of the
gene. Because the human IL4R gene promoter has not
previously been characterized, we BLAST-searched using
the human IL4R cDNA sequence (Idzerda et al, 1990; Galizzi
et al, 1990) and identified a human genomic BAC
CIT987SK-582J2 (accession: AC004525), which spanned
the entire IL4R gene. We identified the IL4R transcription
initiation site by 50-RACE and by primer-extension analysis.
Primer extension analysis, using a 35-mer oligonucleotide
primer 50-CGCCGTCCGGGCGCCCAAGCGGGAAGTGGG-
GGACC-30 derived from exon 1, yielded a major extension
product of approximately 115 nt and a minor primer-
extension product of 107 nt, indicating the existence of one
major and one minor mRNA 50 terminus, indicated in Fig 1
by arrow and arrowhead, respectively. The major mRNA 50
end is numbered as þ 1. Sequence search for transcription
factor motifs (TFSEARCH: http://pdap1.trc.rwcp.or.jp/
research/db/TFSEARCHJ.html) showed putative binding
sites for Oct-1 (from 30 to 17), Sp-1 (from 96 to 87
and from 42 to 33), NF-kB (from 113 to 104), and
MZF-1 (myeloid zinc finger protein-1) to the polymorphic
site (327/326) (Fig 1). The STAT binding site (from 402
to 391) (STAT: signal transducer and activator of transcrip-
tion) reported in the mouse IL4R promoter (Kotanides et al,
1996) has not been evolutionarily conserved in the human.
By direct sequencing of the IL4R promoter region,
we identified six polymorphisms: 3112C4T, 1803T4C,
327C4A,326A4C, 186G4A, and 184A4G. The re-
sults of the case–control study are summarized in Table I. In
the atopic dermatitis group, the 3112Tallele is significantly
more frequent than 3112C (p¼0.0075). Also in the atopic
dermatitis group, the genotype TT at –3112 is significantly
more frequent than the genotypes CC plus CT (p¼ 0.0018).
Similarly, all of the polymorphisms showed significant asso-
ciations with atopic dermatitis, except –184A4G. Strongest
association was observed for –327C4A. The –327A allele is
significantly more frequent in atopic dermatitis than the
–327C allele (p¼0.00033). We showed here for the first time
that the proximal promoter polymorphisms of the IL4R gene
are associated with atopic dermatitis. The distal polymorph-
isms, 3112C4T and 1803T4C, have already been
described by Hackstein et al (2001) as 3223C4T and
1914T4C, numbered from the first nucleotide of the exon
1 that had been published. We did not find 890T4C,
which was reported also by Hackstein et al (2001), probably
due to the difference of the study population.
From the direct sequencing data of the promoter,
the proximal four polymorphisms, 327C4A, 326A4C,
Figure1
Structure of the transcriptional promoter of human IL4R gene.
Nucleotide sequence of the IL4R promoter. Potential binding se-
quences for the transcription factors MZF-1, NF-kB, Sp-1, and Oct-1
are shown by lower horizontal arrows. Transcription initiation sites are
indicated by vertical arrows, the major transcription initiation site is
shown by a thick arrow and the minor one is shown by a thin arrow.
Abbreviations: STAT, signal transducer and activator of transcrip-
tion; TGF-b1, transforming growth factor-b1
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186G4A, and 184A4G, appeared to form three
haplotypes: a (yACyA.Ay), b (yCAyG.Ay), and g
(yAAyG.Ay). Among patients with atopic dermatitis, we
observed 162 a haplotypes (80%) versus 99 (66%) among
controls. The frequency of b haplotypes was 29 (14%)
among patients with atopic dermatitis, versus 46 (31%)
among normal controls (Table II). Thus, the frequency of the
a haplotype is significantly higher (Pc¼0.0093) and that of
the b haplotype is significantly lower (Pc¼0.00099) in
atopic dermatitis than among normal controls (Table II).
We constructed reporter genes with polymorphic pro-
moters representing the a haplotype (A at 327 and C at
326) and the b haplotype (C at 327 and A at 326) in
the 50 region up to 467, pPGVB2/a and pPGVB2/b,
respectively. We tested activities of the a and b promoters
in two different cell lines, Jurkat Tcell lymphoma and HaCaT
keratinocyte cell lines. In six independent transfection
experiments with Jurkat and HaCaT cells, we found no
statistical difference in basal promoter activities between
pPGVB2/a and pPGVB2/b.
Table I. Association study of IL4R promoter polymorphism (atopic dermatitis versus normal controls)a
Atopic dermatitis Normal control P valueb
Polymorphism n (%) n (%)
3112C4T Allele C 64 (32) 69 (46)
T 138 (68) 81 (54) 0.0075
Genotype CC 14 (14) 14 (19)
CT 36 (36) 41 (55)
TT 51 (50) 20 (26) 0.0018
1803T4C Allele T 42 (21) 53 (35)
C 160 (79) 97 (65) 0.0034
Genotype TT 4 (4) 8 (11)
TC 34 (34) 37 (49)
CC 63 (62) 30 (40) 0.0038
327C4A Allele C 29 (14) 46 (31)
A 173 (86) 104 (69) 0.00033
Genotype CC 3 (3) 8 (11)
CA 23 (23) 30 (40)
AA 75 (74) 37 (49) 0.00086
326A4C Allele A 40 (20) 51 (34)
C 162 (80) 99 (66) 0.0031
Genotype AA 4 (4) 9 (12)
AC 32 (32) 33 (44)
CC 65 (64) 33 (44) 0.009
186G4A Allele G 40 (20) 51 (34)
A 162 (80) 99 (66) 0.0031
Genotype GG 4 (4) 9 (12)
GA 32 (32) 33 (44)
AA 65 (64) 33 (44) 0.009
184A4G Allele A 183 (91) 137 (91) NS
G 19 (9) 13 (9)
Genotype AA 84 (83) 63 (84) NS
AG 15 (15) 11 (15)
GG 2 (2) 1 (1)
aOne hundred and one atopic dermatitis patients (ages 7–72, mean 28.2) were enrolled in this study. Diagnosis was made by the standard criteria
(Hanifin and Rajka, 1980). Seventy-five subjects who denied any atopic diseases (atopic dermatitis, bronchial asthma, allergic rhinitis, allergic
conjunctivitis) were enrolled as normal controls (ages 19–71, mean 33.7).
bPolymorphism data were analyzed by the Fisher’s exact test, two sided, calculated with 2BY2 software, version 1.50. (Utility programs for analysis of
genetic linkage by J. Ott, 1998.)
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We also tested whether IL-4 stimulation might affect IL4R
promoter activity of the two different haplotypes. Stimulation
of Jurkat cells with 4 or 8 ng per mL IL-4 did not affect the
promoter activity of either haplotype. We further extended
the promoter assays using reporter gene constructs
containing longer upstream regions with polymorphic sites.
We observed no significant difference in basal promoter
activities of the 1803T and 1803C alleles in the 1978 to
þ191 region on the b haplotype, or between the 3112C
and 3112T alleles in the 3313 to þ191 region on the b
haplotype, both in Jurkat and in HaCaT cells. Computer-
aided transcription factor search predicted that GATA-3, a
Th2-type zinc-finger transcription factor, should bind only to
the 3112T allele (consensus binding sequence (A/T) GATA
(A/G)) (Patient et al, 2002). GATA-3 plays a critical role in
Th2 development (Ranganath et al, 2001), consistent with
greater frequency of the 3112T allele among patients with
atopic dermatitis. Co-transfection using a GATA-3 expres-
sion vector however, did not upregulate IL4R promoter
activity of our luciferase reporter system. In addition,
treatment with TGF-b1, which stimulates intrinsic GATA-3
(Blokzijl et al, 2002), also did not augment the transcriptional
activity of the 3112T allele. Thus, we found no evidence
that the different polymorphic IL4R gene promoters have
different promoter activities in vitro. Nevertheless, these
promoter variants, which show significant associations with
atopic dermatitis, may well affect function in critical ways
in vivo.
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Table II. Frequency of proximal promoter haplotypes
Haplotype AD n (%) control n (%) P value Pc value
a 162 (80) 99 (66) 0.0031 0.0093
b 29 (14) 46 (31) 0.00033 0.00099
g 11 (6) 5 (3) NS NS
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